<span>Divide $200 by 80 to get $2.50 price per zap. At 3%, Jermaine's $200 would grow to $206 ($200 x 1.03) = $206 by the end of the year. At the end of one year he would have $6 more and would be able to purchase two more zaps (2 X ($2.50 X 1.03), or 2 X $2.575 = $5.15) He would have $.85 left in change.</span>
Answer:
A
Explanation:
The quality should be about the same.
The social responsibility should also be about the same.
There shouldn't be side effects of most products. If you are speaking of medications, there really ought to be the same side effects with the same severity and the same statistical occurrences.
The only difference is the company selling the product.
There have been exceptions to this where different "fillers" were used in the generic brand and the side effects were different and more severe. I've only heard of one case however and I cannot remember what it was. Manufacturers were careful not to let it happen again.
Answer: (A) Market maturity
Explanation:
The market maturity is one of the stage in the product life cycle where is basically refers to the sales growth where the product sales growth get increased and then suddenly get slows down.
The market maturity stage is basically known as the longest stage in the product life cycle. In this life cycle stage the organization reaches to the highest level during the demand cycle.
Therefore, Option (A) is correct.
Answer:
the fund balance is $1,727,056.25
Explanation:
The computation of the fund balance is shown below:
Given that
PMT = $125,000
NPER = 10
RATE = 7%
PV = $0
The formula is shown below:
= -FV(RATE,NPER,PMT,PV,TYPE)
After applying the above formula, the fund balance is $1,727,056.25
Here basically the future value formula should be applied
first party is the one that I would do
